BI1744-HCl

Ingoa matū:

(R)-6-hydroxy-8-(1-hydroxy-2-((1-(4-methoxyphenyl)-2-methylpropan-2-yl)amino)ethyl)-2H-benzo[b][1,4 ]oxazin-3(4H)-kotahi hydrochloride

Waehere SMILES:

O=C1NC2=CC(O)=CC([C@@H](O)CNC(C)(C)CC3=CC=C(OC)C=C3)=C2OC1.[H]Cl

Waehere InChi:

InChI=1S/C21H26N2O5.ClH/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24) 9-1 7-20(16)28-12-19(26)23-17;/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26);1H/t18 -;/m0./s1

Kī InChi:

KCEHVJZZIGJAAW-FERBBOLQSA-N

Kupumatua:

BI-1744,Striverdi, 868049-49-4

Wairewa:Wairewa ki te H2O

Rokiroki:0 - 4°C mo te wa poto (ra ki nga wiki), -20°C ranei mo te wa roa (marama).

Whakaahuatanga:

Ko te BI 1744, he mahi agonist beta-adrenoceptor roa e whakamahia ana hei whakamohoatanga mo te rongoa i nga turoro me te mate pukupuku obstructive pulmonary (COPD), i hangaia e Boehringer-Ingelheim.

Whāinga: LABA